These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 10817513

  • 1. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M, Koomägi R.
    Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
    [Abstract] [Full Text] [Related]

  • 2. The implications of proliferation and apoptosis for lung cancer metastasis.
    Volm M, Koomagi R.
    Oncol Rep; 1999 May; 6(2):373-6. PubMed ID: 10023008
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer.
    Volm M, Koomägi R.
    Anticancer Res; 2000 May; 20(3A):1527-33. PubMed ID: 10928066
    [Abstract] [Full Text] [Related]

  • 4. Cellular predictive factors for the drug response of lung cancer.
    Volm M, Rittgen W.
    Anticancer Res; 2000 May; 20(5B):3449-58. PubMed ID: 11131647
    [Abstract] [Full Text] [Related]

  • 5. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K, Sugimachi K.
    Cancer Res; 1993 Oct 15; 53(20):5000-3. PubMed ID: 8104690
    [Abstract] [Full Text] [Related]

  • 6. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 Oct 15; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 7. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
    Rades D, Setter C, Dahl O, Schild SE, Noack F.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):442-7. PubMed ID: 20950963
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 01; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma.
    Törmänen U, Eerola AK, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto VP, Pääkkö P.
    Cancer Res; 1995 Dec 01; 55(23):5595-602. PubMed ID: 7585640
    [Abstract] [Full Text] [Related]

  • 12. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S, Unsal E, Demirag F, Köksal D, Yilmaz A.
    Respir Med; 2006 Dec 01; 100(12):2220-6. PubMed ID: 16650973
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
    Bellotti M, Elsner B, Paez De Lima A, Esteva H, Marchevsky AM.
    Mod Pathol; 1997 Dec 01; 10(12):1221-7. PubMed ID: 9436967
    [Abstract] [Full Text] [Related]

  • 15. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 01; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 16. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S, Nakagawa T, Miyahara R, Kawano Y, Takenaka K, Yanagihara K, Otake Y, Katakura H, Wada H, Tanaka F.
    Clin Cancer Res; 2005 Feb 01; 11(3):1198-202. PubMed ID: 15709189
    [Abstract] [Full Text] [Related]

  • 17. Analysis of Fas (Apo-1/CD95) expression in non-small cell lung cancer.
    Esposito V, Baldi A, Liuzzi G, Tonini G, Vincenzi B, Persichetti P, Santini M, Ambrogi V, Mineo TC, Montesarchio V, Wolner E, Baldi F, Groeger AM.
    Anticancer Res; 2003 Feb 01; 23(6C):4901-5. PubMed ID: 14981943
    [Abstract] [Full Text] [Related]

  • 18. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B, Lötterle H, Schanzenbächer U, Lah TT, Kalman E, Kayser K, Bülzebruck H, Schirren J, Krasovec M, Kos J, Spiess E.
    Br J Cancer; 1999 Oct 01; 81(3):510-9. PubMed ID: 10507778
    [Abstract] [Full Text] [Related]

  • 19. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 01; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 20. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y, Watanabe H, Sato Y, Hirashima S, Yanagawa T, Matsubara H, Ooi A.
    J Pathol; 2006 Dec 01; 210(4):431-40. PubMed ID: 17029220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.